Control of vessel sprouting by genetic and metabolic determinants

Trends in Endocrinology and Metabolism

Volumn 24, Issue 12, 2013, Pages 589-596

  Eelen, Guy ^a   Cruys, Bert ^a   Welti, Jonathan ^a   De Bock, Katrien ^a   Carmeliet, Peter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Angiogenesis; Branching; Filopodia; Glycolysis; PFKFB3; Tip cell

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; F ACTIN; FATTY ACID; FRUCTOSE 2,6 BISPHOSPHATE; GLUCOSE TRANSPORTER 1; GLUTAMINE; LACTATE DEHYDROGENASE; LACTIC ACID; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; VASCULOTROPIN; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; BLOOD VESSEL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; ENDOTHELIUM CELL; GENETIC REGULATION; GLUCOSE METABOLISM; GLYCOLYSIS; METABOLIC REGULATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; VESSEL SPROUTING;

ANGIOGENESIS; BRANCHING; FILOPODIA; GLYCOLYSIS; PFKFB3; TIP CELL;

ANIMALS; ENDOTHELIAL CELLS; GLYCOLYSIS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOFRUCTOKINASE-2;

EID: 84888138948     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.08.006     Document Type: Review

References (67)

1. Potente M., et al. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146:873-887.
2. Siekmann A.F., et al. The tip cell concept 10 years after: new players tune in for a common theme. Exp. Cell Res. 2013, 319:1255-1263.
3. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
4. Chung A.S., Ferrara N. Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 2011, 27:563-584.
5. Eilken H.M., Adams R.H. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr. Opin. Cell Biol. 2010, 22:617-625.
6. Saharinen P., et al. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol. Med. 2011, 17:347-362.
7. Vander Heiden M.G., et al. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
8. De Bock K., et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 2013, 154:651-663.
9. Peters K., et al. Changes in human endothelial cell energy metabolic capacities during in vitro cultivation. The role of 'aerobic glycolysis' and proliferation. Cell. Physiol. Biochem. 2009, 24:483-492.
10. Polet F., Feron O. Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. J. Intern. Med. 2013, 273:156-165.
11. Dranka B.P., et al. Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 2010, 48:905-914.
12. Yeh W.L., et al. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 2008, 73:170-177.
13. Parra-Bonilla G., et al. Critical role for lactate dehydrogenase A in aerobic glycolysis that sustains pulmonary microvascular endothelial cell proliferation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:L513-L522.
14. Van Schaftingen E., et al. A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur. J. Biochem. 1982, 129:191-195.
15. Locasale J.W., Cantley L.C. Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 2011, 14:443-451.
16. Buchwald P. A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets. Theor. Biol. Med. Model. 2011, 8:20.
17. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 2004, 14:198-206.
18. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
19. Mertens S., et al. Energetic response of coronary endothelial cells to hypoxia. Am. J. Physiol. 1990, 258:H689-H694.
20. Pan S., et al. Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2009, 29:895-901.
21. Leopold J.A., et al. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J. Biol. Chem. 2003, 278:32100-32106.
22. Vizan P., et al. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets. Carcinogenesis 2009, 30:946-952.
23. Zhang Z., et al. High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J. 2010, 24:1497-1505.
24. Krutzfeldt A., et al. Metabolism of exogenous substrates by coronary endothelial cells in culture. J. Mol. Cell. Cardiol. 1990, 22:1393-1404.
25. Favaro E., et al. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells. Cell Metab. 2012, 16:751-764.
26. Lohmann R., et al. Rat liver endothelial cell glutamine transporter and glutaminase expression contrast with parenchymal cells. Am. J. Physiol. 1999, 276:G743-G750.
27. Wu G., et al. Glutamine metabolism in endothelial cells: ornithine synthesis from glutamine via pyrroline-5-carboxylate synthase. Comp. Biochem. Physiol. A: Mol. Integr. Physiol. 2000, 126:115-123.
28. DeBerardinis R.J., Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010, 29:313-324.
29. Hinshaw D.B., Burger J.M. Protective effect of glutamine on endothelial cell ATP in oxidant injury. J. Surg. Res. 1990, 49:222-227.
30. Unterluggauer H., et al. Premature senescence of human endothelial cells induced by inhibition of glutaminase. Biogerontology 2008, 9:247-259.
31. Dagher Z., et al. Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells. Circ. Res. 2001, 88:1276-1282.
32. Hagberg C.E., et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 2010, 464:917-921.
33. Reihill J.A., et al. The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and -B in human aortic endothelial cells. Vasc. Cell 2011, 3:9.
34. Elmasri H., et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J. 2009, 23:3865-3873.
35. Jakobsson L., et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 2010, 12:943-953.
36. Phng L.K., Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev. Cell 2009, 16:196-208.
37. Arima S., et al. Angiogenic morphogenesis driven by dynamic and heterogeneous collective endothelial cell movement. Development 2011, 138:4763-4776.
38. Phng L.K., et al. Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev. Cell 2009, 16:70-82.
39. Guarani V., et al. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 2011, 473:234-238.
40. Potente M., et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007, 21:2644-2658.
41. Merchan J.R., et al. Antiangiogenic activity of 2-deoxy-D-glucose. PLoS ONE 2010, 5:e13699.
42. Vaisman N., et al. Characterization of the receptors for vascular endothelial growth factor. J. Biol. Chem. 1990, 265:19461-19466.
43. Benedito R., et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 2009, 137:1124-1135.
44. Vegran F., et al. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 2011, 71:2550-2560.
45. Sonveaux P., et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS ONE 2012, 7:e33418.
46. Ruan G.X., Kazlauskas A. Lactate engages receptor tyrosine kinases Axl, Tie2 and VEGFR-2 to activate PI3K/Akt and promote angiogenesis. J. Biol. Chem. 2013, 288:21161-21172.
47. Hunt T.K., et al. Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid. Redox Signal. 2007, 9:1115-1124.
48. Fraisl P., et al. Regulation of angiogenesis by oxygen and metabolism. Dev. Cell 2009, 16:167-179.
49. Hunt T.K., et al. Lactate, with oxygen, incites angiogenesis. Adv. Exp. Med. Biol. 2008, 614:73-80.
50. Fraccaroli A., et al. Visualization of endothelial actin cytoskeleton in the mouse retina. PLoS ONE 2012, 7:e47488.
51. Yogurtcu O.N., et al. A mechanochemical model of actin filaments. Biophys. J. 2012, 103:719-727.
52. Pollard T.D. Regulation of actin filament assembly by Arp2/3 complex and formins. Annu. Rev. Biophys. Biomol. Struct. 2007, 36:451-477.
53. Romero S., et al. How ATP hydrolysis controls filament assembly from profilin-actin: implication for formin processivity. J. Biol. Chem. 2007, 282:8435-8445.
54. Lim K.B., et al. The Cdc42 effector IRSp53 generates filopodia by coupling membrane protrusion with actin dynamics. J. Biol. Chem. 2008, 283:20454-20472.
55. Real-Hohn A., et al. Filamentous actin and its associated binding proteins are the stimulatory site for 6-phosphofructo-1-kinase association within the membrane of human erythrocytes. Biochimie 2010, 92:538-544.
56. Baquer N.Z., et al. Positional information and pattern regulation in hydra: enzyme profiles. J. Embryol. Exp. Morphol. 1975, 33:853-867.
57. Mitchell B.F., et al. ATP production in Chlamydomonas reinhardtii flagella by glycolytic enzymes. Mol. Biol. Cell 2005, 16:4509-4518.
58. Hertz L., et al. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood Flow Metab. 2007, 27:219-249.
59. Mazzone M., et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009, 136:839-851.
60. Zhang J., et al. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of β-catenin. J. Biol. Chem. 2011, 286:8055-8066.
61. Eklund L., Saharinen P. Angiopoietin signaling in the vasculature. Exp. Cell Res. 2013, 319:1271-1280.
62. Kitajewski J. Endothelial laminins underlie the tip cell microenvironment. EMBO Rep. 2011, 12:1087-1088.
63. Stenzel D., et al. Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. EMBO Rep. 2011, 12:1135-1143.
64. Cavallaro U., Dejana E. Adhesion molecule signalling: not always a sticky business. Nat. Rev. Mol. Cell Biol. 2011, 12:189-197.
65. Giampietro C., et al. Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood 2012, 119:2159-2170.
66. Locasale J.W., Cantley L.C. Altered metabolism in cancer. BMC Biol. 2010, 8:88.
67. Curry F.E., Adamson R.H. Endothelial glycocalyx: permeability barrier and mechanosensor. Ann. Biomed. Eng. 2012, 40:828-839.